Literature DB >> 35084701

18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.

Kathleen A Young1, Melissa Lyle2, Andrew N Rosenbaum1, Ian C Chang1, Grace Lin1, Melanie C Bois3, Omar F Abou Ezzeddine1, Hayan Jouni1, Panithaya Chareonthaitawee1, Suraj Kapa1, Martha Grogan1, Leslie T Cooper2, Lori Blauwet4, John P Bois5.   

Abstract

18F-flurodeoxyglycose (FDG)/13N-ammonia positron emission tomography/computed tomography (PET/CT) is frequently utilized to evaluate cardiac sarcoidosis (CS) but findings can reflect other forms of myocardial inflammation or altered myocardial metabolic activity. Herein, we present five cases where cardiac PET findings suggested CS, but right ventricular endomyocardial biopsy samples revealed ATTR-type cardiac amyloidosis.
© 2022. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.

Entities:  

Keywords:  18F-flurodeoxyglycose PET; ATTR cardiac amyloidosis; Inflammation

Year:  2022        PMID: 35084701     DOI: 10.1007/s12350-021-02886-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  1 in total

1.  Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.

Authors:  Tomohisa Okada; Naoto Kawaguchi; Masao Miyagawa; Marika Matsuoka; Rami Tashiro; Yuki Tanabe; Tomoyuki Kido; Toru Miyoshi; Haruhiko Higashi; Takeshi Inoue; Hideki Okayama; Osamu Yamaguchi; Teruhito Kido
Journal:  J Nucl Cardiol       Date:  2022-07-08       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.